Earnings History Data for Strongbridge Biopharma plc (SBBP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Strongbridge Biopharma plc
Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing's syndrome, COR-004 and COR-005 to treat acromegaly, BP-2001, the treatment of diabetes which are in different clinical trial. Strongbridge Biopharma PLC is based in Trevose, Pennsylvania.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
05-08-2021 | PM | 7:30 AM ET (Aug 5) |
SBBP | Strongbridge Biopharma plc | 156.93 | -0.21 | -0.12 | -0.32 | Strongbridge Biopharma EPS misses by $0.08, beats on revenue [8/5/2021 7:37 AM] |
2.07 | -0.22 (-9.61%) |
2.10 | -0.19 (-8.30%) |
1.87 - 4.40 | 834,087 | 330,000 | 21,933 | |
12-05-2021 | PM | 7:30 AM ET (May 12) |
SBBP | Strongbridge Biopharma plc | 163.46 | -0.18 | -0.13 | -0.24 | Strongbridge Biopharma EPS misses by $0.05, beats on revenue [5/12/2021 7:32 AM] |
2.27 | -0.14 (-5.81%) |
2.34 | -0.07 (-2.90%) |
1.87 - 4.63 | 382,271 | 390,000 | 9,120 | |
|
||||||||||||||||||
03-03-2021 | PM | 7:30 AM ET (Mar 3) |
SBBP | Strongbridge Biopharma plc | 212.49 | -0.18 | -0.17 | -0.17 | Strongbridge Biopharma EPS in-line, beats on revenue [3/3/2021 7:32 AM] |
2.86 | -0.26 (-8.33%) |
3.07 | -0.05 (-1.60%) |
1.50 - 4.63 | 1,357,554 | 1,025,212 | 28,146 | |
29-10-2020 | AH | After the close (Oct 29) |
SBBP | Strongbridge Biopharma plc | 130.28 | -0.18 | -0.25 | -0.31 | Strongbridge Biopharma EPS beats by $0.01, beats on revenue [10/29/2020 4:37 PM] |
1.94 | 0.06 (2.91%) |
1.97 | 0.08 (4.23%) |
1.43 - 4.63 | 609,025 | 380,985 | 7,218 | |
|
||||||||||||||||||
04-08-2020 | PM | 7:30 AM ET (Aug 4) |
SBBP | Strongbridge Biopharma plc | 182.81 | -0.32 | -0.24 | -0.30 | Strongbridge Biopharma EPS beats by $0.08, beats on revenue [8/4/2020 7:32 AM] |
3.88 | 0.31 (8.68%) |
3.65 | 0.08 (2.24%) |
1.43 - 4.63 | 1,131,805 | 198,276 | 7,687 | |
|
||||||||||||||||||
06-05-2020 | PM | SBBP | Strongbridge Biopharma plc | 144.84 | -0.24 | -0.25 | -0.34 | Strongbridge Biopharma EPS beats by $0.04, beats on revenue [5/6/2020 7:32 AM] |
2.61 | -0.06 (-2.25%) |
0.0 | 0.0 (0.00%) |
1.43 - 3.62 | 214,683 | 267,031 | 0 | ||
|